Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits on the host. The Food and Agriculture Organization (FAO) and World Health Organization (WHO) have stated that there is sufficient scientific evidence to support the health benefits of probiotics, and specific strains are safe for human use. However, the term "probiotic" is not yet standardized, and many products marketed as probiotics lack proper identification, documentation, and clinical validation. In clinical practice, probiotics are not widely used in North America, with many physicians lacking knowledge or accurate information about their benefits. While some probiotic products are used by alternative practitioners, their efficacy and safety remain uncertain. The current research environment has not provided sufficient clinical testing for many probiotic strains. Probiotics have shown effectiveness in treating and preventing various conditions, particularly in newborns and children. For example, Lactobacillus rhamnosus GG and Bifidobacterium lactis BB-12 have been shown to reduce the duration of rotavirus-induced diarrhea in children. Additionally, probiotics have been used to treat antibiotic-associated Clostridium difficile infections, with some studies showing reduced recurrence rates. Probiotics may also help in managing Helicobacter pylori infections, inflammatory bowel diseases, and allergies. For instance, L. rhamnosus GG has been shown to reduce the risk of atopic eczema in at-risk infants. In women's reproductive and bladder health, probiotics have been used to prevent bacterial vaginosis and urinary tract infections, with some studies showing significant reductions in infection rates. In surgical infections, probiotics have shown potential in preventing Staphylococcus aureus infections. Additionally, probiotics may help in reducing postoperative infections in high-risk patients. However, more research is needed to establish standardized guidelines for the use of probiotics in clinical practice. The effectiveness of probiotics in various conditions remains to be fully validated, and further studies are required to determine their safety and efficacy.Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits on the host. The Food and Agriculture Organization (FAO) and World Health Organization (WHO) have stated that there is sufficient scientific evidence to support the health benefits of probiotics, and specific strains are safe for human use. However, the term "probiotic" is not yet standardized, and many products marketed as probiotics lack proper identification, documentation, and clinical validation. In clinical practice, probiotics are not widely used in North America, with many physicians lacking knowledge or accurate information about their benefits. While some probiotic products are used by alternative practitioners, their efficacy and safety remain uncertain. The current research environment has not provided sufficient clinical testing for many probiotic strains. Probiotics have shown effectiveness in treating and preventing various conditions, particularly in newborns and children. For example, Lactobacillus rhamnosus GG and Bifidobacterium lactis BB-12 have been shown to reduce the duration of rotavirus-induced diarrhea in children. Additionally, probiotics have been used to treat antibiotic-associated Clostridium difficile infections, with some studies showing reduced recurrence rates. Probiotics may also help in managing Helicobacter pylori infections, inflammatory bowel diseases, and allergies. For instance, L. rhamnosus GG has been shown to reduce the risk of atopic eczema in at-risk infants. In women's reproductive and bladder health, probiotics have been used to prevent bacterial vaginosis and urinary tract infections, with some studies showing significant reductions in infection rates. In surgical infections, probiotics have shown potential in preventing Staphylococcus aureus infections. Additionally, probiotics may help in reducing postoperative infections in high-risk patients. However, more research is needed to establish standardized guidelines for the use of probiotics in clinical practice. The effectiveness of probiotics in various conditions remains to be fully validated, and further studies are required to determine their safety and efficacy.